and left ventricular (LV) dysfunction, receiving current standard pharmacological therapy. Conclusion: The mortality and morbidity of patients with LV dysfunction and FMR remain high despite ...
had non-ischaemic LV systolic dysfunction, with a mean EF of 34.4 ± 10.8% (range 10–48%). Sixteen per cent of patients underwent mitral valve surgery; 166 patients (41.2%) had mild MR ...
This cross sectional study assessed the prevalence and determinants of cognitive dysfunction in older patients with mild to moderate heart failure ... The MMSE score was associated with left ...
Background: HJIG is a potential treatment for erectile dysfunction (ED) that has been used in China for over 20 years. We conducted a multi-center, double-blind, randomized, placebo-controlled trial ...
The prevalence and impact of right ventricular dysfunction (RVD) in degenerative mitral regurgitation (DMR) is unknown. We aimed to determine whether RVD assessed by echocardiography in routine ...
19 Initial deterioration in LVEF is associated with a worse clinical outcome and is predictive of lower LVEF at follow-up.1 26 In our cohort, LVEF was 58±11%, reflecting relatively preserved or mild ...
but the potential for cerebral emboli persists in the large population of patients with chronic LV dysfunction. Since these thromboembolic events are usually unheralded by warning signs of transient ...
Bohbot et al report that an elevated sPAP ≥50 mm Hg in addition to left ventricular ejection fraction ≤60% were the strongest factors ... the prognostic value of subclinical ventricular dysfunction ...
Some people who develop COVID-19 experience a mild illness with few symptoms while others can become seriously ill. COVID-19 is the illness that’s caused by the novel coronavirus, SARS-CoV-2.
We, therefore, aimed to document PHT and its impact on mortality among adults with left ventricular (LV) diastolic dysfunction (LVDD). Methods We analysed the profile and outcomes of 16 058 adults ...